Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Multi-omics Evaluation of an Immune-mediated Preclinical Model Reveals Novel Targets for Meibomian Gland Dysfunction
Author Affiliations & Notes
  • Agnes Acevedo
    Ophthalmology Discovery, AbbVie Inc, Irvine, California, United States
  • Kevin Kipp
    Ophthalmology Discovery, AbbVie Inc, Irvine, California, United States
  • Dolly Mistry
    Ophthalmology Discovery, AbbVie Inc, Irvine, California, United States
  • Mansour Dughbaj
    Ophthalmology Discovery, AbbVie Inc, Irvine, California, United States
  • Justyna Resztak
    Computational Genomics, Genomics Research Center, AbbVie Inc, North Chicago, Illinois, United States
  • Alice Wan
    Computational Genomics, Genomics Research Center, AbbVie Inc, North Chicago, Illinois, United States
  • Christopher Ling
    Small Molecule Therapeutics & Platform Technologies, AbbVie Inc, North Chicago, Illinois, United States
  • Audrey Nguyen
    Local Delivery Translational Science, Pathology group, AbbVie Inc, Irvine, California, United States
  • Lydia Andrews-Jones
    Local Delivery Translational Science, Pathology group, AbbVie Inc, Irvine, California, United States
  • Areej Ammar
    Genomic Technologies, Genomics Research Center, AbbVie Inc, North Chicago, Illinois, United States
  • Elina Regan
    Genomic Technologies, Genomics Research Center, AbbVie Inc, North Chicago, Illinois, United States
  • Alvis Hu
    Genomic Technologies, Genomics Research Center, AbbVie Inc, North Chicago, Illinois, United States
  • Katherine S Held
    Ophthalmology Discovery, AbbVie Inc, Irvine, California, United States
  • Footnotes
    Commercial Relationships   Agnes Acevedo Abbvie, Code E (Employment); Kevin Kipp Abbvie, Code E (Employment); Dolly Mistry Abbvie, Code E (Employment); Mansour Dughbaj Abbvie, Code E (Employment); Justyna Resztak Abbvie, Code E (Employment); Alice Wan Abbvie, Code E (Employment); Christopher Ling Abbvie, Code E (Employment); Audrey Nguyen Abbvie, Code E (Employment); Lydia Andrews-Jones Abbvie, Code E (Employment); Areej Ammar Abbvie, Code E (Employment); Elina Regan Abbvie, Code E (Employment); Alvis Hu Abbvie, Code E (Employment); Katherine Held Abbvie, Code E (Employment)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 5766. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Agnes Acevedo, Kevin Kipp, Dolly Mistry, Mansour Dughbaj, Justyna Resztak, Alice Wan, Christopher Ling, Audrey Nguyen, Lydia Andrews-Jones, Areej Ammar, Elina Regan, Alvis Hu, Katherine S Held; Multi-omics Evaluation of an Immune-mediated Preclinical Model Reveals Novel Targets for Meibomian Gland Dysfunction. Invest. Ophthalmol. Vis. Sci. 2024;65(7):5766.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Dry Eye Disease (DED) is a complex disorder of the tear film, impacting vision and causing discomfort. The tear film consists of three layers: the lipid, aqueous, and mucin. The majority of DED is classified as evaporative dry eye, due to dysfunction and/or atrophy of the meibomian glands (MG), termed Meibomian Gland Dysfunction (MGD). MGD pathogenesis remains unclear, therefore, to better understand MGD and identify potential new targets we implemented a multi-omics approach leveraging the Allergic Eye Disease (AED) mouse model, which exhibits characteristics of MGD.

Methods : AED was induced in C57BL6 female mice following immunization then topical challenge with ovalbumin (OVA) and tearing, eyelid swelling, conjunctival chemosis, and MG plugging were monitored. Eyelids from naïve and AED were dissected to evaluate inflammation and gland changes using spatial transcriptomics (GeoMx, NanoString). Meibum was expressed from eyelids to assess if AED caused meibum lipid composition changes through liquid chromatography high-resolution mass spectrometry.

Results : Our findings reveal that the AED model displays many MGD characteristics, such as MG plugging, structural changes, and inflammation markers. Gene set enrichment analysis (GSEA) of spatially resolved transcriptome changes showed a significant increase of inflammatory changes in the inter-acini space (e.g., T cell differentiation (q-value≈0.09), response to IL-17 (q-value≈0.08), leukocyte aggregation (q-value≈0.01), and neutrophil migration (q-value≈4*10-4)) with AED. There was also a significant decrease in the expression of extracellular matrix (ECM) assembly, and SMAD protein signal transduction limited to the duct (q-value≈0.08 and 4*10-3, respectively) and acini (q-value≈0.06 and 1*10-3, respectively) compartments. However, while changes in meibum lipid content are associated to MGD, we did not find significant alterations after five days of ocular OVA challenge, suggesting that longer-term MG environment changes might be necessary to affect meibum lipid composition.

Conclusions : While the AED model does not fully replicate all aspects of MGD, it serves as a useful tool for studying immune-mediated changes related to MGD. Our results support further research to explore extracellular matrix (ECM) and SMAD as potential targets for MGD.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×